686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
Publication/Presentation Date
5-2020
Volume
158
Issue
6
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS
